Browsing by Author Bacoyiannis, C.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 2 to 8 of 8 < previous 
TitleAuthor(s)Issue date???itemlist.???
Docetaxel and gemcitabine combination, as first-line treatment, in patients with extensive disease small-cell lung cancer. A phase II study of the Hellenic Cooperative Oncology GroupSkarlos, D. V.; Dimopoulos, A. M.; Kosmidis, P.; Papakostas, P.; Pavlidis, N.; Bacoyiannis, C.; Kiamouris, C.; Klouvas, G.; Gogas, H.; Fountzilas, G.; Samantas, E.24-Nov-2015-
Paclitaxel and gemcitabine in advanced non-nasopharyngeal head and neck cancer: a phase II study conducted by the Hellenic Cooperative Oncology GroupFountzilas, G.; Stathopoulos, G.; Nicolaides, C.; Kalogera-Fountzila, A.; Kalofonos, H.; Nikolaou, A.; Bacoyiannis, C.; Samantas, E.; Papadimitriou, C.; Kosmidis, P.; Daniilidis, J.; Pavlidis, N.24-Nov-2015-
Paclitaxel by three-hour infusion and carboplatin in advanced carcinoma of nasopharynx and other sites of the head and neck. A phase II study conducted by the Hellenic Cooperative Oncology GroupFountzilas, G.; Skarlos, D.; Athanassiades, A.; Kalogera-Fountzila, A.; Samantas, E.; Bacoyiannis, C.; Nicolaou, A.; Dombros, N.; Briasoulis, E.; Dinopoulou, M.; Stathopoulos, G.; Pavlidis, N.; Kosmidis, P.; Daniilidis, J.24-Nov-2015-
Paclitaxel in combination with carboplatin or gemcitabine for the treatment of advanced head and neck cancerFountzilas, G.; Athanassiades, A.; Kalogera-Fountzila, A.; Samantas, E.; Bacoyiannis, C.; Briassoulis, E.; Pavlidis, N.; Kosmidis, P.; Skarlos, D.24-Nov-2015-
Prognostic factors influencing complete response to treatment and survival of patients with nasopharyngeal cancerKalogera-Fountzila, A.; Kosmidis, P.; Bacoyiannis, C.; Nicolaou, A.; Samantas, E.; Briassoulis, E.; Pavlidis, N.; Skarlos, D.; Daniilidis, J.; Fountzilas, G.24-Nov-2015-
Vinblastine and interferon-gamma combination with and without 13-cis retinoic acid for patients with advanced renal cell carcinoma. Results of two phase II clinical trialsBacoyiannis, C.; Dimopoulos, M. A.; Kalofonos, H. P.; Nicolaides, C.; Aravantinos, G.; Bafaloukos, D.; Samelis, G.; Onyenadum, A.; Kiamouris, Ch; Skarlos, D.; Pavlidis, N.; Triantafillidis, A.; Kosmidis, P.24-Nov-2015-
Vinorelbine versus paclitaxel for patients with advanced non-small cell lung cancer (NSCLC) and a performance status of 2Kosmidis, P. A.; Syrigos, K.; Kalofonos, H. P.; Dimopoulos, M. A.; Skarlos, D.; Pavlidis, N.; Boukovinas, I.; Bafaloukos, D.; Pectasides, D.; Bacoyiannis, C.; Fountzilas, G.24-Nov-2015-